- Home
- BLLN vs VSNT Comparison
BLLN vs VSNT Comparison
Compare BLLN & VSNT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | BLLN | VSNT |
|---|---|---|
| Founded | 2016 | 2025 |
| Country | United States | United States |
| Employees | 713 | 4400 |
| Industry | Medical Specialities | Broadcasting |
| Sector | Health Care | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 5.8B | 6.0B |
| IPO Year | N/A | N/A |
Fundamental Metrics
Financial Performance| Metric | BLLN | VSNT |
|---|---|---|
| Price | $98.28 | $36.56 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 7 | 3 |
| Target Price | ★ $126.71 | $43.67 |
| AVG Volume (30 Days) | 784.7K | ★ 1.8M |
| Earning Date | 05-06-2026 | 05-14-2026 |
| Dividend Yield | N/A | ★ 3.79% |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $46.29 | N/A |
| Revenue Next Year | $30.14 | N/A |
| P/E Ratio | ★ N/A | $3.83 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $61.96 | $27.17 |
| 52 Week High | $150.44 | $45.58 |
Technical Indicators
Market Signals| Indicator | BLLN | VSNT |
|---|---|---|
| Relative Strength Index (RSI) | 37.20 | 49.02 |
| Support Level | $73.46 | $34.95 |
| Resistance Level | $108.50 | $37.79 |
| Average True Range (ATR) | 8.11 | 1.30 |
| MACD | -5.35 | 0.28 |
| Stochastic Oscillator | 15.41 | 25.12 |
Price Performance
Historical ComparisonAbout BLLN BillionToOne Inc.
BillionToOne Inc is a molecular diagnostics company. It offers a portfolio of ultrasensitive tests covering prenatal genetic testing, cancer therapy selection, and response monitoring, which are based on its Quantitative Counting Templates (QCT) molecular counting platform. The company's product portfolio comprises UNITY, a portfolio of prenatal testing products that can conduct fetal risk analysis without requiring a paternal sample; Northstar Select, a ultrasensitive liquid biopsy test that provides insights into appropriate therapies for stage III or IV cancer patients; and Northstar Response, a tissue-free, pan-cancer, liquid biopsy test that measures several genomic loci uniquely methylated in cancer to provide insight into dynamic changes in therapy response.
About VSNT Versant Media Group Inc. Class A Common Stock
Versant Media Group Inc is an independent media company comprised of NBCUniversal's cable television networks, including USA Network, CNBC, MSNBC, Oxygen, SYFY, and Golf Channel, along with complementary digital assets Fandango, Rotten Tomatoes, GolfNow, GolfPass, and SportsEngine.